Zobrazeno 1 - 10
of 71
pro vyhledávání: '"A. V. G. Bruschke"'
Autor:
Laurien E, Zijlstra, Marianne, Bootsma, J Wouter, Jukema, Martin J, Schalij, Hubert W, Vliegen, Albert V G, Bruschke
Publikováno v:
International journal of cardiology. 280
Patients presenting with chest pain suggestive of coronary artery disease (CAD) who at coronary arteriography appear to be free of obstructive disease have presented a diagnostic and therapeutic challenge since the 1970's. Studies in female patient p
Autor:
E. E. van der Wall, A. V. G. Bruschke, A. A. Voors, H.E Westerveld, A. H. Zwinderman, J. E. Roeters Van Lennep, H.W.O. Roeters van Lennep, H. W. M. Plokker
Publikováno v:
European Heart Journal, 21(11), 911-918. Oxford University Press
Aims. The aim of the present clinical study was to evaluate whether gender-related differences existed as regards the extent and localization of coronary artery lesions in patients with angiographically documented coronary artery disease, and whether
Autor:
Kong I. Lie, J. A. Kuivenhoven, Ruth McPherson, Johan Wouter Jukema, A. V. G. Bruschke, P. de Knijff, Aeilko H. Zwinderman, John J. P. Kastelein
Publikováno v:
New England Journal of Medicine. 338:86-93
Background The high-density lipoprotein (HDL) cholesterol concentration is inversely related to the risk of coronary artery disease. The cholesteryl ester transfer protein (CETP) has a central role in the metabolism of this lipoprotein and may theref
Publikováno v:
Cardiovascular Drugs and Therapy. 12:111-118
Lipid-lowering therapy now has undoubtedly proven to be an effective therapeutic modality to retard the progression of coronary atherosclerosis. An additional approach for prevention of the progression of atherosclerosis is calcium channel blocker (C
Autor:
Henk J. Blom, Godfried H.J. Boers, Johan Wouter Jukema, Sandra G. Heil, J.J.P. Kastelein, Leo A. J. Kluijtmans, F.J.M. Trijbels, F.F. Willems, L.P.W.J. van den Heuvel, Freek W.A. Verheugt, Jan Lindemans, G.J.M. Boerma, A. V. G. Bruschke
Publikováno v:
Circulation. 96:2573-2577
Background Hyperhomocysteinemia, an independent and graded risk factor for coronary artery disease (CAD), may result from both environmental and hereditary factors. Methylenetetrahydrofolate reductase (MTHFR) catalyzes the conversion of methylenetetr
Autor:
E. A. van der Velde, E. E. van der Wall, B. L. F. Van Eck-Smit, M.J. Schalij, P. J. Voogd, Johan H. C. Reiber, A. van der Laarse, Leo H.B. Baur, J. J. Schipperheyn, M I Sedney, A. V. G. Bruschke
Publikováno v:
European Heart Journal. 18:1313-1321
The present study was designed to evaluate the effects of early angiotensin converting enzyme (ACE) inhibition on left ventricular enlargement in patients with anterior wall infarction following reperfusion therapy.Seventy-one consecutive patients wi
Autor:
A. V. G. Bruschke, B. L. F. Van Eck-Smit, A. H. Zwinderman, S. Poots, E. E. van der Wall, Ernest K. J. Pauwels
Publikováno v:
Nuclear Medicine Communications. 18:24-30
99Tcm-tetrofosmin is a new myocardial perfusion agent with the advantage that it can be reconstituted at room temperature. Because two separate injections are required for rest and stress images, a separate-day imaging protocol with one injection eac
Autor:
AJ van Boven, Hans Jansen, J.H.C. Reiber, J.A. Henneman, E. Gagne, T. Bruin, G.P. Molhoek, A. V. G. Bruschke, A. H. Zwinderman, Michael R. Hayden, J.J.P. Kastelein, Joop Jukema, Björn E. Groenemeijer
Publikováno v:
Circulation, 94(8), 1913-1918. LIPPINCOTT WILLIAMS & WILKINS
Background Many patients suffering from premature coronary artery disease report a family history for such events. A mutation in a particular gene, which confers susceptibility for atherosclerosis, will be found more frequently in individuals sufferi
Autor:
Babette M Pluim, A. de Roos, E. E. van der Wall, R. M. J. N. Lamerichs, A. V. G. Bruschke, Hubert W. Vliegen, J. Doornbos, A. van der Laarse, J. C. Chin, Hmj Siebelink
Publikováno v:
European Heart Journal. 17:1271-1278
We investigated whether left ventricular hypertrophy in elite cyclists is associated with functional changes or abnormal energy metabolism. Left ventricular hypertrophy is a powerful risk factor for sudden cardiac death with different prognostic sign
Autor:
Ernest K. J. Pauwels, E. E. van der Wall, Aaf F. M. Kuijper, A. V. G. Bruschke, M. G. Niemeyer, B. L. F. Van Eck-Smit, A. H. Zwinderman
Publikováno v:
Nuclear Medicine Communications. 17:659-668
Reinjection of thallium-201 (201Tl) improves the detection of myocardial ischaemia in approximately 50% of irreversible defects present on 3 h redistribution images. Additional reinjection studies, however, may limit the capacity of the nuclear labor